Pharmaceutical Group Pharmaceutical Group

Biothera is developing Imprime PGG®, a phase 3 cancer immunotherapy that directs innate immune cells to recognize and kill antibody-targeted tumor cells. In phase 2 clinical trials, Imprime PGG has demonstrated marked improvements in response rates in multiple clinical trials for non-small cell lung cancer, colorectal cancer and chronic lymphocytic leukemia.

Healthcare Group Healthcare Group

Biothera manufactures and markets Wellmune WGP® and other immune health ingredients that help keep the body healthy for use in functional foods, beverages, nutritional supplements, cosmetics and animal nutrition products. Products containing our food-grade ingredients are found in more than 60 countries.

Site design by Checkerboard